Core Viewpoint - The company, 北海康成-B (01228), has entered into a subscription agreement with 百洋健康产业国际商贸有限公司 to issue 74.9715 million shares at a subscription price of HKD 1.34 per share, representing a discount of approximately 19.76% from the closing price of HKD 1.67 on August 11, 2025 [1] Group 1 - The total amount raised from the subscription will be HKD 100 million, with a net amount estimated at approximately HKD 98.6618 million after deducting related expenses [1] - The net proceeds from the subscription are intended to be used for (i) research and development of commercialized products; (ii) marketing and promotional activities; (iii) repayment of loan financing and borrowings; and (iv) general operational activities of the group [1] - Trading of the company's shares was suspended on the Hong Kong Stock Exchange from 9:00 AM on August 12, 2025, at the request of the company, pending the announcement [1]

Core Viewpoint - North Sea Kangcheng-B (01228) has entered into a subscription agreement with Baiyang Health Industry International Trade Co., Ltd. to issue 74.9715 million subscription shares at a price of HKD 1.34 per share, representing a discount of approximately 19.76% from the closing price of HKD 1.67 on August 11, 2025 [1] Group 1 - The total amount raised from the subscription will be HKD 100 million, with a net amount estimated at approximately HKD 98.6618 million after deducting related expenses [1] - The net proceeds from the subscription will be used for (i) research and development of commercialized products; (ii) marketing and promotional activities; (iii) repayment of loan financing and borrowings; and (iv) daily operations of the group [1] - Trading of the shares has been suspended on the Hong Kong Stock Exchange from 9:00 AM on August 12, 2025, at the company's request, with a resumption of trading expected on August 13, 2025 [1]

Core Viewpoint - Feidao Tourism Technology (08069) plans to issue a total of 136 million shares to ASPECT, Inc., representing approximately 16.67% of the company's expanded issued share capital after the issuance [1] Group 1: Share Issuance Details - The subscription price is set at HKD 0.0306 per share, which is a discount of about 4.38% compared to the closing price of HKD 0.032 per share on August 1 [1] - The total amount raised from the subscription is approximately HKD 4.17 million, with a net amount of about HKD 4 million [1] Group 2: Use of Proceeds - The net proceeds are intended to be used for promoting the school travel market and the tourism industry [1]

Core Viewpoint - China Ruyi (00136) has announced a subscription agreement with Infinity Capital Management Limited, involving the conditional subscription of 1.3 billion shares at a price of HKD 3.00 per share, representing approximately 7.51% of the enlarged issued share capital [1] Group 1: Subscription Agreement Details - The subscription price of HKD 3.00 per share reflects a discount of approximately 4.46% compared to the closing price of HKD 3.14 on July 31, 2025 [1] - The total net proceeds from the subscription, after deducting related fees and expenses, are expected to be approximately HKD 38.95 billion [1] Group 2: Use of Proceeds - The company plans to allocate the net proceeds as follows: 20% for business growth and expansion, 60% for strategic investments and acquisitions to enhance the group's business, and 20% for general working capital purposes, including advertising, employee costs, technology development services, and rental costs [1]

Group 1 - The company plans to issue a total of 221.5 million shares to specific subscribers, which will represent approximately 12.12% of the enlarged issued share capital after the issuance [1] - The subscription price per share is set at HKD 0.10, reflecting a premium of about 44.93% compared to the closing price of HKD 0.069 on July 29 [1] - The total amount expected to be raised from this placement is HKD 22.15 million, with a net amount of approximately HKD 22.02 million [1] Group 2 - Approximately HKD 13.2 million of the raised funds will be used to repay overdue lease payments and other payables due within three months from the announcement date [1] - About HKD 8.8 million will be allocated for the company's general working capital [1]

待完成后，认购事项所得款项总额及所得款项净额预计将分别约为2215万港元及2202万港元。认购事项 的所得款项净额拟定用途为：约1320万港元用作偿还集团逾期应付租赁款项及其他将于本公布日期起3 个月内到期的未偿还债券应付款项及应付租赁款项;及约880万港元用作集团一般营运资金。 创业集团控股(02221)发布公告，于2025年7月29日，公司拟向认购人(沈定女士、赵素梅女士、黄智俊先 生、张红兵女士)配发及发行合共2.215亿股认购股份，相当于公司经配发及发行认购股份扩大后之已发 行股本的约12.12%。每股认购股份的认购价为0.10港元，较7月29日收市价每股股份0.069港元溢价约 44.93%。 ...

Core Viewpoint - The company plans to issue a total of 221.5 million subscription shares, representing approximately 12.12% of the enlarged issued share capital after the issuance, at a subscription price of HKD 0.10 per share, which is a premium of about 44.93% over the closing price of HKD 0.069 on July 29 [1] Financial Summary - The total amount expected to be raised from the subscription is approximately HKD 22.15 million, with a net amount of about HKD 22.02 million [1] - The net proceeds from the subscription are intended to be used for the repayment of overdue lease payments and other outstanding bond payments due within three months from the announcement date, amounting to approximately HKD 13.2 million, and for general working capital of approximately HKD 8.8 million [1]

于7月29日根据股份购买协议拟以每股对价股份12港元的发行价格，根据一般授权分配及发行总计 198.55万股对价股份。 药师帮(09885)发布公告，于7月8日至7月29日，根据公司于2019年1月1日采纳的2019年股份激励计划， 因行使所获授予的购股权发行合共56.04万股股份。 ...

Group 1 - The company, Pioneer Pharmaceuticals (00399), has entered into subscription agreements with two investors, A and B, to issue a total of 90 million shares at a subscription price of HKD 0.312 per share, which represents a discount of approximately 20% compared to the closing price of HKD 0.39 on the date of the agreements [1][2] - The shares subscribed by Investor A will account for approximately 3.00% of the company's existing issued share capital as of the announcement date, while the shares subscribed by Investor B will account for approximately 1.50% [1] - The total gross proceeds from the subscription will be approximately HKD 28.08 million, with a net amount of approximately HKD 27.78 million, intended for general working capital of the group [2] Group 2 - The board of directors believes that the current market conditions present a good opportunity for the company to strengthen its capital base and financial position through the issuance of subscription shares [2] - The issuance of subscription shares is considered an appropriate means to raise additional funds, as the subscription price is lower than the market price, which was reached after fair negotiations with the investors [2]

Group 1 - The company announced agreements with various subscribers to issue a total of 19.34 million shares at a subscription price of approximately HKD 0.04801 per share [1] - The company also entered into agreements to issue convertible bonds amounting to HKD 15 million each to three different subscribers, with a conversion price of HKD 0.04801 per share [2] - The total gross proceeds from the subscription are approximately HKD 2.79 million, with a net amount of approximately HKD 2.52 million, which will be used to repay group debts and provide working capital [2] Group 2 - The board believes that raising funds through the subscription is reasonable given the recent market conditions, and it provides an opportunity to enhance the company's working capital and financial position [2] - The subscription not only offers fundraising opportunities but also expands the company's shareholder base and capital foundation [2]